Balance Sheet MIRAIT ONE Corporation

Equities

1417

JP3910620008

Construction & Engineering

Delayed Japan Exchange Other stock markets 08:30:15 2026-03-16 pm EDT			5-day change	1st Jan Change
3,673.00 ^JPY	+1.60%		-0.49%	+4.62%

Feb. 13	MIRAIT ONE Corporation Reports Earnings Results for the Nine Months Ended December 31, 2025	CI
Nov. 13	MIRAIT ONE Corporation Announces Dividend for the Second Quarter Ended September 30, 2025, Payable on November 28, 2025	CI

2c3243827abc44ce9c720a4dc9e024c.nqnmvphVLBO3o06ZecJBU8tA-NRTPLY2CP-nisF6Znk.y92rze9hTnjmmy31Ep0UI4gNzJ4WT5tZT5eQ07kDJxzuhJyL_BBlJ87IJQ

Published financial data: MIRAIT ONE CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	464B	470B	484B	518B	579B
Total Revenues	464B	470B	484B	518B	579B
Cost of Goods Sold, Total	403B	404B	423B	457B	494B
Gross Profit	60.79B	66.22B	60.5B	61.78B	84.85B
Selling General & Admin Expenses, Total	29.02B	31.5B	36.19B	41.3B	53.07B
Provision for Bad Debts	45M	-	-	-	-
Depreciation & Amortization - (IS)	1.64B	1.92B	2.5B	2.65B	3.79B
Other Operating Expenses, Total	30.71B	33.41B	38.69B	43.95B	56.87B
Operating Income	30.08B	32.8B	21.8B	17.83B	27.98B
Interest Expense, Total	-48M	-40M	-179M	-208M	-662M
Interest And Investment Income	1.02B	672M	541M	705M	732M
Net Interest Expenses	973M	632M	362M	497M	70M
Income (Loss) On Equity Invest.	-164M	206M	-67M	-169M	-621M
Currency Exchange Gains (Loss)	344M	176M	-126M	379M	-446M
Other Non Operating Income (Expenses)	500M	332M	410M	152M	481M
EBT, Excl. Unusual Items	31.74B	34.15B	22.38B	18.69B	27.47B
Gain (Loss) On Sale Of Investments	4.58B	3.26B	1.08B	1.76B	-7M
Gain (Loss) On Sale Of Assets	18M	619M	110M	179M	935M
Asset Writedown	-302M	-265M	-70M	-166M	-144M
Legal Settlements	-	-	-	-	-
Other Unusual Items	204M	-258M	-260M	30M	-293M
EBT, Incl. Unusual Items	36.24B	37.5B	23.24B	20.49B	27.96B
Income Tax Expense	11.71B	12.07B	8.04B	7.35B	10.08B
Earnings From Continuing Operations	24.53B	25.43B	15.2B	13.14B	17.88B
Net Income to Company	24.53B	25.43B	15.2B	13.14B	17.88B
Minority Interest	-322M	-270M	-420M	-606M	-696M
Net Income - (IS)	24.2B	25.16B	14.78B	12.54B	17.18B
Net Income to Common Incl Extra Items	24.2B	25.16B	14.78B	12.54B	17.18B
Net Income to Common Excl. Extra Items	24.2B	25.16B	14.78B	12.54B	17.18B
Per Share Items
Net EPS - Basic	229.59	250.84	151.19	133.33	189.4
Basic EPS - Continuing Operations	229.59	250.84	151.19	133.33	189.4
Basic Weighted Average Shares Outstanding	105M	100M	97.76M	94.01M	90.7M
Net EPS - Diluted	229.59	250.84	151.19	133.33	189.4
Diluted EPS - Continuing Operations	229.59	250.84	151.19	133.33	189.4
Diluted Weighted Average Shares Outstanding	105M	100M	97.76M	94.01M	90.7M
Normalized Basic EPS	185.09	210.08	138.8	117.81	181.61
Normalized Diluted EPS	185.09	210.08	138.8	117.81	181.61
Dividend Per Share	45	55	60	65	75
Payout Ratio	18.92	19.05	40.08	45.67	37.38
Supplemental Items
EBITDA	37.03B	40.18B	31.26B	28.09B	41.74B
EBITA	30.73B	33.32B	23.23B	19.58B	30.47B
EBIT	30.08B	32.8B	21.8B	17.83B	27.98B
Effective Tax Rate - (Ratio)	32.32	32.18	34.6	35.86	36.07
Normalized Net Income	19.51B	21.07B	13.57B	11.08B	16.47B
Non-Cash Pension Expense	-424M	-375M	-670M	-614M	-1.38B
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	265M	140M	116M	304M	371M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	44.76B	50.93B	32.48B	50.04B	53.48B
Total Cash And Short Term Investments	44.76B	50.93B	32.48B	50.04B	53.48B
Accounts Receivable, Total	153B	185B	195B	210B	229B
Other Receivables	2.31B	3.9B	5.13B	3.8B	3.48B
Total Receivables	155B	189B	200B	214B	232B
Inventory	30.79B	30.91B	31.72B	31.1B	29.17B
Prepaid Expenses	1.17B	1.22B	1.16B	1.63B	1.78B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	1.43B	4.26B	7.1B	7.7B	4.28B
Total Current Assets	233B	276B	273B	305B	321B
Net Property Plant And Equipment	86.66B	91.55B	93.47B	100B	101B
Long-term Investments	28.55B	27.54B	28.05B	36.14B	38.58B
Goodwill	3.09B	27.66B	20.69B	38.57B	37.58B
Other Intangibles, Total	4.46B	6.15B	18.04B	37.1B	39B
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	2.5B	3.65B	4B	3.4B	270M
Other Long-Term Assets, Total	1M	-	2M	1M	2M
Total Assets	359B	433B	437B	520B	538B
Liabilities
Accounts Payable, Total	63.21B	67.79B	67.71B	64.01B	66.48B
Accrued Expenses, Total	8.12B	8.43B	8.65B	11.07B	11.08B
Short-term Borrowings	186M	50.11B	21.5B	75.15B	42.6B
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	3.35B	3.54B	3.3B	3.54B	4.46B
Current Income Taxes Payable	12.16B	10.63B	9B	11.46B	12.31B
Unearned Revenue Current, Total	3.15B	7.34B	5.3B	11.26B	6.71B
Other Current Liabilities	12.84B	10.85B	9.6B	16.18B	17.33B
Total Current Liabilities	103B	159B	125B	193B	161B
Long-Term Debt	-	-	30.01B	31B	70.5B
Long-Term Leases	6.59B	6.3B	6.29B	7.4B	9.94B
Pension & Other Post Retirement Benefits	14.1B	15.44B	15.87B	18.78B	17.65B
Deferred Tax Liability Non Current	1.18B	677M	3.53B	7.62B	5.73B
Other Non Current Liabilities	2.54B	2.35B	1.68B	2.39B	3.07B
Total Liabilities	127B	183B	182B	260B	268B
Common Stock, Total	7B	7B	7B	7B	7B
Additional Paid In Capital	69.57B	69.65B	61.28B	45.78B	40.16B
Retained Earnings	155B	176B	184B	191B	202B
Treasury Stock	-10.89B	-15.84B	-12.33B	-3.79B	-2.93B
Comprehensive Income and Other	5.47B	5.5B	6.82B	12.15B	15.75B
Total Common Equity	226B	242B	247B	252B	262B
Minority Interest	4.93B	7.12B	7.49B	8.11B	8.38B
Total Equity	231B	249B	254B	260B	270B
Total Liabilities And Equity	359B	433B	437B	520B	538B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	101M	98.68M	95.61M	91.35M	89.49M
ECS Total Common Shares Outstanding	101M	98.96M	95.91M	92.1M	89.71M
Book Value / Share	2.23K	2.45K	2.57K	2.74K	2.91K
Tangible Book Value	219B	208B	208B	176B	185B
Tangible Book Value Per Share	2.16K	2.1K	2.17K	1.91K	2.06K
Total Debt	10.12B	59.95B	61.11B	117B	127B
Net Debt	-34.64B	9.02B	28.63B	67.06B	74.02B
Debt Equivalent of Unfunded Proj. Benefit Obligation	10.99B	7.65B	8.68B	7.44B	5.44B
Minority Interest, Total (Incl. Fin. Div)	4.93B	7.12B	7.49B	8.11B	8.38B
Inventories - Raw Materials, Total	3.4B	3.62B	4.15B	4.49B	4.12B
Inventories - Work In Process, Total	26.04B	25.84B	25.23B	25.55B	24.26B
Inventories - Finished Goods, Total	1.34B	1.45B	2.33B	1.06B	791M
Full Time Employees	12.88K	14.01K	14.35K	16.98K	17.12K
Accumulated Allowance for Doubtful Accounts (Supple)	26M	15M	12M	237M	247M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	36.24B	37.5B	23.24B	20.49B	27.96B
Depreciation & Amortization - CF	6.3B	6.86B	8.03B	8.51B	11.26B
Amortization of Goodwill and Intangible Assets - (CF)	648M	514M	1.43B	1.75B	2.49B
Depreciation & Amortization, Total	6.95B	7.38B	9.46B	10.26B	13.75B
(Gain) Loss From Sale Of Asset	285M	-353M	-40M	-12M	-790M
(Gain) Loss on Sale of Investments - (CF)	-4.64B	-3.26B	-1.08B	-1.96B	-892M
(Income) Loss On Equity Investments - (CF)	164M	-206M	67M	169M	621M
Other Operating Activities, Total	-8.99B	-14.39B	-10.05B	-6.35B	-8.06B
Change In Accounts Receivable	331M	-4.3B	-7.98B	5.79B	-15.61B
Change In Inventories	1.95B	486M	-984M	799M	2.1B
Change In Accounts Payable	8.9B	-7.81B	-470M	-7.15B	3.95B
Change in Other Net Operating Assets	411M	-2.08B	-6.85B	11.59B	-4.98B
Cash from Operations	41.6B	12.97B	5.32B	33.62B	18.05B
Capital Expenditure	-8.38B	-8.59B	-5.6B	-6.01B	-5.69B
Sale of Property, Plant, and Equipment	72M	785M	363M	386M	3.07B
Cash Acquisitions	-271M	-43.41B	-	-49.86B	-5.09B
Sale (Purchase) of Intangible assets	-534M	-2.35B	-2.24B	-2.48B	-2.07B
Investment in Marketable and Equity Securities, Total	11.18B	8.28B	-1.71B	2.83B	831M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-734M	-103M	-261M	297M
Other Investing Activities, Total	-190M	-184M	-3.03B	-148M	-710M
Cash from Investing	1.87B	-46.2B	-12.31B	-55.54B	-9.37B
Short Term Debt Issued, Total	-	49.92B	-	53.5B	-
Long-Term Debt Issued, Total	-	-	29.83B	-	40B
Total Debt Issued	-	49.92B	29.83B	53.5B	40B
Short Term Debt Repaid, Total	-16.61B	-	-28.6B	-	-32.54B
Long-Term Debt Repaid, Total	-19M	-26M	-24M	-50M	-644M
Total Debt Repaid	-16.63B	-26M	-28.63B	-50M	-33.18B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-9.57B	-5B	-6B	-7.52B	-4B
Common Dividends Paid	-4.58B	-4.79B	-5.92B	-5.72B	-6.42B
Common & Preferred Stock Dividends Paid	-4.58B	-4.79B	-5.92B	-5.72B	-6.42B
Other Financing Activities, Total	-1.42B	-1.7B	-1.84B	-1.38B	-2.8B
Cash from Financing	-32.2B	38.4B	-12.57B	38.82B	-6.41B
Foreign Exchange Rate Adjustments	-202M	810M	1.07B	720M	1.07B
Miscellaneous Cash Flow Adjustments	149M	75M	1M	1M	-
Net Change in Cash	11.22B	6.05B	-18.5B	17.62B	3.33B
Supplemental Items
Cash Interest Paid	49M	40M	179M	211M	664M
Cash Income Tax Paid (Refund)	9.07B	14.43B	10.1B	6.38B	8.09B
Levered Free Cash Flow	35.15B	-14B	-4.47B	11.92B	9.9B
Unlevered Free Cash Flow	35.18B	-13.98B	-4.35B	12.05B	10.31B
Change In Net Working Capital	-18.35B	30.92B	19.6B	862M	13.16B
Net Debt Issued / Repaid	-16.63B	49.89B	1.2B	53.45B	6.82B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.29	5.18	3.13	2.33	3.31
Return on Total Capital	7.71	7.45	4.36	3.22	4.52
Return On Equity %	10.9	10.58	6.04	5.11	6.75
Return on Common Equity	10.96	10.74	6.05	5.03	6.69
Margin Analysis
Gross Profit Margin %	13.11	14.08	12.5	11.92	14.66
SG&A Margin	6.26	6.7	7.48	7.97	9.17
EBITDA Margin %	7.99	8.54	6.46	5.42	7.21
EBITA Margin %	6.63	7.08	4.8	3.78	5.27
EBIT Margin %	6.49	6.97	4.5	3.44	4.84
Income From Continuing Operations Margin %	5.29	5.41	3.14	2.53	3.09
Net Income Margin %	5.22	5.35	3.05	2.42	2.97
Net Avail. For Common Margin %	5.22	5.35	3.05	2.42	2.97
Normalized Net Income Margin	4.21	4.48	2.8	2.14	2.85
Levered Free Cash Flow Margin	7.58	-2.98	-0.92	2.3	1.71
Unlevered Free Cash Flow Margin	7.59	-2.97	-0.9	2.32	1.78
Asset Turnover
Asset Turnover	1.3	1.19	1.11	1.08	1.09
Fixed Assets Turnover	5.48	5.28	5.23	5.36	5.75
Receivables Turnover (Average Receivables)	3.02	2.78	2.55	2.56	2.63
Inventory Turnover (Average Inventory)	12.68	13.1	13.52	14.54	16.38
Short Term Liquidity
Current Ratio	2.27	1.74	2.18	1.58	2
Quick Ratio	1.94	1.51	1.86	1.37	1.78
Operating Cash Flow to Current Liabilities	0.4	0.08	0.04	0.17	0.11
Days Sales Outstanding (Average Receivables)	120.68	131.12	143.22	143.08	138.59
Days Outstanding Inventory (Average Inventory)	28.78	27.86	26.99	25.17	22.28
Average Days Payable Outstanding	55.5	59.13	58.28	52.86	48.42
Cash Conversion Cycle (Average Days)	93.95	99.84	111.93	115.4	112.45
Long Term Solvency
Total Debt/Equity	4.38	24.05	24.03	45.02	47.24
Total Debt / Total Capital	4.19	19.39	19.37	31.04	32.08
LT Debt/Equity	2.85	2.53	14.27	14.77	29.8
Long-Term Debt / Total Capital	2.73	2.04	11.51	10.18	20.24
Total Liabilities / Total Assets	35.52	42.4	41.77	49.98	49.81
EBIT / Interest Expense	626.77	820.12	121.81	85.73	42.27
EBITDA / Interest Expense	771.48	1K	174.64	135.06	63.05
(EBITDA - Capex) / Interest Expense	596.83	789.8	143.38	106.17	54.45
Total Debt / EBITDA	0.27	1.49	1.95	4.17	3.05
Net Debt / EBITDA	-0.94	0.22	0.92	2.39	1.77
Total Debt / (EBITDA - Capex)	0.35	1.9	2.38	5.3	3.54
Net Debt / (EBITDA - Capex)	-1.21	0.29	1.12	3.04	2.05
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.12	1.43	2.89	7.11	11.62
Gross Profit, 1 Yr. Growth %	16.51	8.92	-8.64	2.13	37.34
EBITDA, 1 Yr. Growth %	30.44	8.51	-22.21	-10.13	48.57
EBITA, 1 Yr. Growth %	36.63	8.41	-30.28	-15.71	55.63
EBIT, 1 Yr. Growth %	36.79	9.04	-33.53	-18.22	56.95
Earnings From Cont. Operations, 1 Yr. Growth %	57.43	3.69	-40.23	-13.55	36.02
Net Income, 1 Yr. Growth %	59.03	3.96	-41.26	-15.2	37.05
Normalized Net Income, 1 Yr. Growth %	37.97	7.99	-35.61	-18.38	48.73
Diluted EPS Before Extra, 1 Yr. Growth %	53.13	9.26	-39.72	-11.81	42.05
Accounts Receivable, 1 Yr. Growth %	-0.37	20.83	5.42	7.94	8.84
Inventory, 1 Yr. Growth %	-6.01	0.41	2.59	-1.95	-6.18
Net Property, Plant and Equip., 1 Yr. Growth %	4.91	5.65	2.09	7.1	1
Total Assets, 1 Yr. Growth %	1.88	20.61	0.94	19.05	3.42
Tangible Book Value, 1 Yr. Growth %	4.85	-4.81	-0.1	-15.27	4.88
Common Equity, 1 Yr. Growth %	5.09	6.95	1.94	2.09	3.78
Cash From Operations, 1 Yr. Growth %	424.22	-68.82	-59.03	532.64	-46.32
Capital Expenditures, 1 Yr. Growth %	-13.84	2.49	-34.88	7.4	-5.24
Levered Free Cash Flow, 1 Yr. Growth %	-577.72	-139.84	-68.11	-366.95	-16.95
Unlevered Free Cash Flow, 1 Yr. Growth %	-580.33	-139.73	-68.85	-376.8	-14.41
Dividend Per Share, 1 Yr. Growth %	12.5	22.22	9.09	8.33	15.38
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.07	3.26	2.16	4.98	9.34
Gross Profit, 2 Yr. CAGR %	13.74	12.65	-0.24	-3.41	18.43
EBITDA, 2 Yr. CAGR %	21.32	18.97	-8.12	-16.39	15.55
EBITA, 2 Yr. CAGR %	20.76	21.71	-13.06	-23.34	14.53
EBIT, 2 Yr. CAGR %	20.63	22.13	-14.87	-26.27	13.29
Earnings From Cont. Operations, 2 Yr. CAGR %	-2.8	27.77	-21.27	-28.12	8.44
Net Income, 2 Yr. CAGR %	-2.97	28.58	-21.86	-29.42	7.81
Normalized Net Income, 2 Yr. CAGR %	20.25	22.07	-16.61	-27.51	10.18
Diluted EPS Before Extra, 2 Yr. CAGR %	-5.88	29.35	-18.85	-27.09	11.92
Accounts Receivable, 2 Yr. CAGR %	5.2	9.72	12.86	6.67	8.39
Inventory, 2 Yr. CAGR %	4.12	-2.85	1.5	0.29	-4.09
Net Property, Plant and Equip., 2 Yr. CAGR %	4.84	5.28	3.86	4.57	4.01
Total Assets, 2 Yr. CAGR %	4.04	10.85	10.34	9.62	10.96
Tangible Book Value, 2 Yr. CAGR %	7.5	-0.1	-2.49	-8	-5.73
Common Equity, 2 Yr. CAGR %	7.35	6.02	4.41	2.02	2.93
Cash From Operations, 2 Yr. CAGR %	153.16	27.85	-64.26	61	84.28
Capital Expenditures, 2 Yr. CAGR %	-27.96	-6.02	-18.3	-16.37	0.88
Levered Free Cash Flow, 2 Yr. CAGR %	8.2	37.96	-64.36	-7.74	48.9
Unlevered Free Cash Flow, 2 Yr. CAGR %	8.27	38.15	-64.82	-7.15	53.92
Dividend Per Share, 2 Yr. CAGR %	6.07	17.26	15.47	8.71	11.8
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.01	7.76	3.14	3.78	7.15
Gross Profit, 3 Yr. CAGR %	15.2	12.11	5.06	0.54	8.62
EBITDA, 3 Yr. CAGR %	22.58	16.89	3.26	-8.8	1.27
EBITA, 3 Yr. CAGR %	21.59	16.5	1.08	-13.95	-2.93
EBIT, 3 Yr. CAGR %	21.64	16.64	-0.29	-16	-5.16
Earnings From Cont. Operations, 3 Yr. CAGR %	27.37	-0.68	-0.82	-18.78	-11.09
Net Income, 3 Yr. CAGR %	28.14	-0.72	-0.97	-19.7	-11.95
Normalized Net Income, 3 Yr. CAGR %	21.87	16.01	-1.37	-17.21	-7.88
Diluted EPS Before Extra, 3 Yr. CAGR %	22.12	-1.09	0.28	-16.57	-8.94
Accounts Receivable, 3 Yr. CAGR %	17.6	10.17	8.26	11.19	7.39
Inventory, 3 Yr. CAGR %	12.9	2.87	-1.07	0.33	-1.91
Net Property, Plant and Equip., 3 Yr. CAGR %	24.53	5.11	4.21	4.93	3.37
Total Assets, 3 Yr. CAGR %	14.9	9.29	7.44	13.17	7.51
Tangible Book Value, 3 Yr. CAGR %	18.73	3.23	-0.1	-6.95	-3.89
Common Equity, 3 Yr. CAGR %	18.15	7.22	4.64	3.63	2.6
Cash From Operations, 3 Yr. CAGR %	49.06	25.96	-12.51	-6.85	11.64
Capital Expenditures, 3 Yr. CAGR %	-5.75	-18.98	-16.84	-10.5	-12.82
Levered Free Cash Flow, 3 Yr. CAGR %	173.48	-22.45	-15.33	-30.26	-10.92
Unlevered Free Cash Flow, 3 Yr. CAGR %	172.38	-22.48	-15.92	-30.03	-9.64
Dividend Per Share, 3 Yr. CAGR %	8.74	11.2	14.47	13.04	10.89
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.46	10.68	9.11	6.64	5.57
Gross Profit, 5 Yr. CAGR %	18.62	14.57	8.76	5.63	10.21
EBITDA, 5 Yr. CAGR %	33.57	24.82	9.23	2.23	8.01
EBITA, 5 Yr. CAGR %	37.32	26.09	6.32	-1.46	6.26
EBIT, 5 Yr. CAGR %	37.59	26.66	5.46	-2.92	4.94
Earnings From Cont. Operations, 5 Yr. CAGR %	43.52	30.26	5.07	-12.73	2.79
Net Income, 5 Yr. CAGR %	46.14	31.35	5.14	-13.38	2.45
Normalized Net Income, 5 Yr. CAGR %	38.63	27.42	4.71	-3.88	3.09
Diluted EPS Before Extra, 5 Yr. CAGR %	38.75	29.3	3.71	-12.45	4.79
Accounts Receivable, 5 Yr. CAGR %	13.26	15.09	15.68	8.75	8.31
Inventory, 5 Yr. CAGR %	12.25	11.92	8.19	1.83	-2.29
Net Property, Plant and Equip., 5 Yr. CAGR %	22.25	21.48	15.81	4.89	4.13
Total Assets, 5 Yr. CAGR %	12.97	14.69	13.05	9.42	8.84
Tangible Book Value, 5 Yr. CAGR %	12.61	12.2	9.74	-1.42	-2.39
Common Equity, 5 Yr. CAGR %	12.99	14.3	12.45	5.11	3.95
Cash From Operations, 5 Yr. CAGR %	46.15	22.17	-15.8	38.95	17.86
Capital Expenditures, 5 Yr. CAGR %	19.55	18.98	-10.99	-17.94	-10.16
Levered Free Cash Flow, 5 Yr. CAGR %	70.52	54.87	21.05	-16.87	6.12
Unlevered Free Cash Flow, 5 Yr. CAGR %	70.52	55.46	20.12	-16.68	7.09
Dividend Per Share, 5 Yr. CAGR %	8.45	12.89	11.38	10.2	13.4